Business Wire

TX-MARY-KAY

8.6.2023 18:03:31 CEST | Business Wire | Press release

Share
Mary Kay Celebrates Oceans Week by Reaffirming Partnership With the Nature Conservancy

Mary Kay is celebrating Ocean’s Week by reaffirming its decades-long partnership with The Nature Conservancy (TNC) to support ocean conservation and coral reef protection. Coral reefs, often referred to as the rainforests of the sea, cover less than 1% of the world’s surface area but support 25% of all marine life and over one billion people.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230608005582/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Dr. Elizabeth McLeod, The Nature Conservancy’s Global Oceans Director, conducting research in Ulong Channel, Palau as part of the Super Reefs project, a collaborative effort to discover the secrets of “super reefs” with support from Mary Kay. (Credit: © Kip Evans/CCC Marketing)

Because traditional reef conservation strategies have not been enough to counter the global loss of coral reefs, Mary Kay, a signatory to the UN Global Compact Sustainable Ocean Principles, is supporting experts from TNC, Woods Hole Oceanographic Institution (WHOI), and Stanford University as they lead a collaborative effort to discover the secrets of “super reefs” – a diverse coral community within a reef system that is more resistant or resilient to damaging heatwaves – in efforts to predict, prove, and protect critical coral reefs.

Mary Kay’s continued support of TNC’s Global Oceans and Super Reefs programs allows researchers to assess reef health, identify potential super reef locations, and discuss opportunities to improve reef management locally. This information will help guide conservation and restoration efforts. Current areas of interest for super reefs work include Hawaii, Palau, Indonesia, the Marshall Islands, the Bahamas, the Dominican Republic, and Belize.

“Like all rivers and tributaries, most good things in our world lead back to oceans,” said Deborah Gibbins, Chief Operations Officer at Mary Kay Inc. “Mary Kay is working with partners like The Nature Conservancy to protect Earth’s most valuable resources. Clean, healthy water isn’t just essential to our business—it’s essential for life everywhere.”

“TNC is committed to conserving 4 billion hectares of the ocean by 2030, and we are grateful for support from Mary Kay to help achieve this critical goal. Strong partnerships with governments, non-profits, companies, and local communities are essential to our success,” said Dr. Lizzie Mcleod, TNC’s Global Oceans Director.

This year, Mary Kay will also continue its support of the Coastal Wetlands in Texas, the beauty brand’s home state. In 2023, TNC will continue working toward its three-year project objectives:

  • identify priority wetland areas for protection and restoration across more than 27,000 kilometers of shoreline along the Gulf of Mexico,
  • produce a Coastal Conservation and Restoration Action Plan for Texas’ three blue carbon ecosystems—mangroves, salt marsh, and seagrass—including mapping areas where we expect wetlands will migrate in the future due to climate change,
  • assess the feasibility of blue carbon markets to support long-term wetland management needs in Texas, and
  • identify a dynamic coastal wetland site that can be established as a “living laboratory” to share conservation techniques, explore blue carbon offsets, and highlight the importance of these critical ecosystems.

In 1990, Mary Kay and TNC announced their partnership. Mary Kay’s conservation efforts started off close to home, focusing on protecting and preserving the natural resources of Texas. Over the last 33 years, Mary Kay’s support has grown to hundreds of projects in partnership with TNC including ocean work and coral reef restoration around the globe. Through its partnership with TNC, Mary Kay has also elevated women’s leadership in marine conservation to sustain programs that build gender equity into conservation efforts.

About Mary Kay

Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.

About The Nature Conservancy

The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters and oceans at an unprecedented scale, providing food and water sustainably and helping make cities more sustainable. Working in 76 countries and territories—37 by direct conservation impact and 39 through partners—we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230608005582/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release

Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi

Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme

Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release

Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting

Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release

On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-

Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release

Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye